RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in Japan

Masahide Mizobuchi, Hiroaki Ogata, Yoshihiro Onishi, Shingo Fukuma, Tadao Akizawa, Shunichi Fukuhara
  • Therapeutic Apheresis, August 2017, Wiley
  • DOI: 10.1111/1744-9987.12540

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/1744-9987.12540

The following have contributed to this page: Professor Hiroaki Ogata

In partnership with: